169 related articles for article (PubMed ID: 37145891)
1. Epidemiology, Phenotypic and Genotypic Characterization of Carbapenem-Resistant Gram-Negative Bacteria from a Libyan Hospital.
Slimene K; Salabi AE; Dziri O; Mathlouthi N; Diene SM; Mohamed EA; Amhalhal JMA; Aboalgasem MO; Alrjael JF; Rolain JM; Chouchani C
Microb Drug Resist; 2023 Aug; 29(8):333-343. PubMed ID: 37145891
[TBL] [Abstract][Full Text] [Related]
2. Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018.
Lee YL; Lu MC; Shao PL; Lu PL; Chen YH; Cheng SH; Ko WC; Lin CY; Wu TS; Yen MY; Wang LS; Liu CP; Lee WS; Shi ZY; Chen YS; Wang FD; Tseng SH; Lin CN; Chen YH; Sheng WH; Lee CM; Liao MH; Hsueh PR
Int J Antimicrob Agents; 2019 Sep; 54(3):318-328. PubMed ID: 31202925
[TBL] [Abstract][Full Text] [Related]
3. Isolation of Carbapenem and Colistin Resistant Gram-Negative Bacteria Colonizing Immunocompromised SARS-CoV-2 Patients Admitted to Some Libyan Hospitals.
Slimene K; Ali AA; Mohamed EA; El Salabi A; Suliman FS; Elbadri AA; El-Fertas FF; El-Awjly A; Shokri SA; Rolain JM; Chouchani C
Microbiol Spectr; 2023 Jun; 11(3):e0297222. PubMed ID: 37042782
[TBL] [Abstract][Full Text] [Related]
4. Carbapenemase-Encoding Genes and Colistin Resistance in Gram-Negative Bacteria During the COVID-19 Pandemic in Mexico: Results from the Invifar Network.
Garza-Ramos U; Silva-Sánchez J; López-Jácome LE; Hernández-Durán M; Colín-Castro CA; Sánchez-Pérez A; Rodríguez-Santiago J; Morfín-Otero R; Rodriguez-Noriega E; Velázquez-Acosta MD; Vázquez-Larios MDR; Feliciano-Guzmán JM; Rojas-Larios F; Ponce-De-Leon A; Lozano-Garcia M; Choy-Chang EV; López-Gutiérrez E; Molina-Jaimes A; Gil-Veloz M; Corte-Rojas RE; López-Ovilla I; Ramirez-Mis JL; Rodríguez-Balderas DE; Molina-Chavarria A; Padilla-Ibarra C; Quevedo-Ramos MA; Mireles-Dávalos CD; Rodríguez-Medina N; Rubio-Mendoza D; Córdova-Fletes C; Cruz-López F; Becerra-Montejano DA; Mercado-Longoria R; Martínez-Villarreal RT; Barlandas-Rendón NRE; Mena-Ramírez JP; Couoh-May CA; Alcaraz-Espejel M; Adame-Alvarez C; Hernández-Vicente L; Garza-González E
Microb Drug Resist; 2023 Jun; 29(6):239-248. PubMed ID: 36595348
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of colistin-resistant, carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Croatia.
D'Onofrio V; Conzemius R; Varda-Brkić D; Bogdan M; Grisold A; Gyssens IC; Bedenić B; Barišić I
Infect Genet Evol; 2020 Jul; 81():104263. PubMed ID: 32105865
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of mgrB gene regulator and resistance to colistin is becoming endemic in carbapenem-resistant Klebsiella pneumoniae in Greece: A nationwide study from 2014 to 2017.
Hamel M; Chatzipanagiotou S; Hadjadj L; Petinaki E; Papagianni S; Charalampaki N; Tsiplakou S; Papaioannou V; Skarmoutsou N; Spiliopoulou I; Christofidou M; Papamichalopoulos N; Skalidis T; Legakis N; Fountoulis K; Perivolioti E; Kraniotaki H; Bournia M; Ioannidis A; Baron Sophie A; Rolain JM
Int J Antimicrob Agents; 2020 Apr; 55(4):105930. PubMed ID: 32130981
[TBL] [Abstract][Full Text] [Related]
7. Comparative genome analysis of colistin-resistant OXA-48-producing Klebsiella pneumoniae clinical strains isolated from two Iranian hospitals.
Bolourchi N; Shahcheraghi F; Giske CG; Nematzadeh S; Noori Goodarzi N; Solgi H; Badmasti F
Ann Clin Microbiol Antimicrob; 2021 Oct; 20(1):74. PubMed ID: 34688302
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of metallo-β-lactamase acquired genes among carbapenems susceptible and resistant Gram-negative clinical isolates using multiplex PCR, Khartoum hospitals, Khartoum Sudan.
Adam MA; Elhag WI
BMC Infect Dis; 2018 Dec; 18(1):668. PubMed ID: 30558551
[TBL] [Abstract][Full Text] [Related]
9. Emergence of mcr-1 gene and carbapenemase-encoding genes among colistin-resistant Klebsiella pneumoniae clinical isolates in Jordan.
Gharaibeh MH; Alyafawi DA; Elnasser ZA; Lafi SQ; Obeidat HM
J Infect Public Health; 2022 Aug; 15(8):922-929. PubMed ID: 35878515
[TBL] [Abstract][Full Text] [Related]
10. Genetic characterisation of carbapenem-resistant Gram-negative bacteria isolated from the University Hospital Mohamed Boudiaf in Ouargla, southern Algeria.
Yagoubat M; Ould El-Hadj-Khelil A; Malki A; Bakour S; Touati A; Rolain JM
J Glob Antimicrob Resist; 2017 Mar; 8():55-59. PubMed ID: 28007519
[TBL] [Abstract][Full Text] [Related]
11. NDM-1 (New Delhi metallo beta lactamase-1) producing Gram-negative bacilli: emergence & clinical implications.
Fomda BA; Khan A; Zahoor D
Indian J Med Res; 2014 Nov; 140(5):672-8. PubMed ID: 25579151
[TBL] [Abstract][Full Text] [Related]
12. Carbapenem and colistin-resistant bacteria in North Lebanon: Coexistence of mcr-1 and NDM-4 genes in Escherichia coli.
Al-Bayssari C; Nawfal Dagher T; El Hamoui S; Fenianos F; Makdissy N; Rolain JM; Nasreddine N
J Infect Dev Ctries; 2021 Jul; 15(7):934-342. PubMed ID: 34343118
[TBL] [Abstract][Full Text] [Related]
13. Resistotyping, phenotyping and genotyping of New Delhi metallo-β-lactamase (NDM) among Gram-negative bacilli from Iranian patients.
Shokri D; Rabbani Khorasgani M; Fatemi SM; Soleimani-Delfan A
J Med Microbiol; 2017 Apr; 66(4):402-411. PubMed ID: 28150578
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of Carbapenem Resistance Mechanisms Among Gram-Negative Pathogens in Lebanon: Results of the First Cross-Sectional Countrywide Study.
Hammoudi Halat D; Moubareck CA; Sarkis DK
Microb Drug Resist; 2017 Sep; 23(6):733-743. PubMed ID: 28080212
[TBL] [Abstract][Full Text] [Related]
15. Detection of NDM-1 and VIM Genes in Carbapenem-Resistant Klebsiella pneumoniae Isolates from a Tertiary Health-Care Center in Kathmandu, Nepal.
Thapa S; Adhikari N; Shah AK; Lamichhane I; Dhungel B; Shrestha UT; Adhikari B; Banjara MR; Ghimire P; Rijal KR
Chemotherapy; 2021; 66(5-6):199-209. PubMed ID: 34515078
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and genotypic detection of carbapenemase production among gram negative bacteria isolated from hospital acquired infections.
Vamsi SK; Moorthy RS; Hemiliamma MN; Chandra Reddy RB; Chanderakant DJ; Sirikonda S
Saudi Med J; 2022 Mar; 43(3):236-243. PubMed ID: 35256490
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and genotypic characterization of carbapenem-resistant
Abouelfetouh A; Torky AS; Aboulmagd E
Antimicrob Resist Infect Control; 2019; 8():185. PubMed ID: 31832185
[TBL] [Abstract][Full Text] [Related]
18. High Carbapenem Resistance in Clinical Gram-Negative Pathogens Isolated in Egypt.
Khalifa HO; Soliman AM; Ahmed AM; Shimamoto T; Hara T; Ikeda M; Kuroo Y; Kayama S; Sugai M; Shimamoto T
Microb Drug Resist; 2017 Oct; 23(7):838-844. PubMed ID: 28191865
[TBL] [Abstract][Full Text] [Related]
19. [In Vitro Activity of Ceftazidime-avibactam and Colistin Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates].
Hoşbul T; Aydoğan CN; Kaya S; Bedir O; Gümral R; Albay A
Mikrobiyol Bul; 2022 Apr; 56(2):218-229. PubMed ID: 35477226
[TBL] [Abstract][Full Text] [Related]
20. Microbial infection pattern, pathogenic features and resistance mechanism of carbapenem-resistant Gram negative bacilli during long-term hospitalization.
Wen S; Feng D; Lu Z; Liu J; Peters BM; Tang H; Su D; Lin YP; Yang L; Xu Z; Shirtliff ME; Chen D
Microb Pathog; 2018 Apr; 117():356-360. PubMed ID: 29452198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
